Partner
← All resources

Interactive tools · STABICON LIFE SCIENCES

Formulation Development Brief Builder

Turn your target product, format, ingredient constraints and scale into a development discussion brief.

Development brief + information gaps

UNDERSTAND BEFORE YOU USE

A little context. A better decision.

Learn → try → review
  1. 01

    Define the target product and format.

  2. 02

    Record ingredients, constraints, scale and available evidence.

  3. 03

    Review the information gaps before requesting a feasibility discussion.

Prepare the target profile and constraints. This tool collects a development brief; it does not design or approve a formula or substantiate a claim.
Information supplied0 / 10
Items to confirm10
Information to bring to the discussion (10)
  • Target product / project
  • Product category and target markets
  • Preferred dosage form / delivery format
  • Target product attributes and intended use
  • Ingredients, restrictions and reporting basis
  • Benchmark / reference product (optional)
  • Development and intended commercial scale
  • Packaging and storage requirements
  • Available specifications, methods and supporting studies
  • Desired milestone / launch window (to agree)

This measures information entered, not technical readiness or approval. You can request a discussion with gaps still open.

ICH Q10 · product and process knowledge ↗
Reference checked 18 November 2026. Confirm current product and market applicability with qualified reviewers.

Review opens an editable Client enquiry draft. Nothing is submitted until you send it. Drafts expire after 30 minutes in this tab.

Read the text output
STABICON · FORMULATION DEVELOPMENT BRIEF BUILDER
Planning output — confirm assumptions and requirements with the laboratory.

DEVELOPMENT DISCUSSION — NO FORMULATION OR PERFORMANCE APPROVAL
Target product / project: To confirm
Product category and target markets: To confirm
Preferred dosage form / delivery format: To confirm
Target product attributes and intended use: To confirm
Ingredients, restrictions and reporting basis: To confirm
Benchmark / reference product (optional): To confirm
Development and intended commercial scale: To confirm
Packaging and storage requirements: To confirm
Available specifications, methods and supporting studies: To confirm
Desired milestone / launch window (to agree): To confirm
OPEN INFORMATION ITEMS
Target product / project
Product category and target markets
Preferred dosage form / delivery format
Target product attributes and intended use
Ingredients, restrictions and reporting basis
Benchmark / reference product (optional)
Development and intended commercial scale
Packaging and storage requirements
Available specifications, methods and supporting studies
Desired milestone / launch window (to agree)
Please review feasibility, responsibilities, applicable requirements and commercial scope.

This output is not a protocol approval, test report, batch-release decision or filing acceptance.
https://stabicon.com/resources/formulation-development-brief

Inputs are not automatically sent or saved by these tools. Download your output before leaving. Technical and market-specific decisions require review.

Stabicon Life Sciences

Science-Led Formulations. Scalable Health Platforms.

Offices

Corporate Office

22, 7th Cross, Jaibharath Nagar, Bengaluru 560 033, Karnataka, India

Research & Development

28, Bommasandra Industrial Area, 4th Phase, Jigani Hobli, Anekal Taluk, Bengaluru 560 099, Karnataka, India

Newsletter

Quarterly briefings on platforms, science & partnerships.

No spam. Request a consent withdrawal at bd@stabicon.com.

Press Kit

Logos, company information & spokesperson details – available from our media team.

Request Press Kit

For media queries: press@stabicon.com

Accreditations

ISO/IEC 17025:2017 (NABL)WHO Geneva – Audited & ApprovedFSSAI ApprovedCDSCO IndiaUS FDA – Registered FacilityDSIR RegisteredAYUSH Registered

Disclaimer: The information provided on this website is for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. These statements have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease. Product packaging and materials may vary from those shown on our website. We recommend that you do not rely solely on the information presented and that you always read labels, warnings, and directions before using or consuming a product.

© 2026 Stabicon Life Sciences Pvt. Ltd. All rights reserved.

Science-Led Formulations. Scalable Health Platforms.

Admin